| 10730873 |
Salts and crystalline forms of an apoptosis-inducing agent |
Shuang Chen, Yuchuan Gong, Geoff G. Zhang |
2020-08-04 |
| 10213433 |
Solid dispersions containing an apoptosis-inducing agent |
David Lindley, Jonathan M. Miller, Eric A. Schmitt, Ping Tong |
2019-02-26 |
| 9840502 |
Salts and crystalline forms of an apoptosis-inducing agent |
Shuang Chen, Yuchuan Gong, Geoff G. Zhang |
2017-12-12 |
| 9403822 |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
Zhi-Fu Tao, Xilu Wang, Andrew J. Souers, Gerard M. Sullivan |
2016-08-02 |
| 9238649 |
Salts and crystalline forms of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide |
Shuang Chen, Yuchuan Gong, Geoff G. Zhang |
2016-01-19 |
| 9006247 |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
Zhi-Fu Tao, Xilu Wang, Andrew J. Souers, Gerard M. Sullivan |
2015-04-14 |
| 8927009 |
ABT-263 capsule |
Ping Tong, Deliang Zhou, Geoff G. Zhang, Katherine Heemstra, Cristina M. Fischer +2 more |
2015-01-06 |
| 8728516 |
Stabilized lipid formulation of apoptosis promoter |
Michael G. Fickes, Cristina M. Fischer, Anthony R. Haight, Katherine Heemstra, Yeshwant D. Sanzgiri +4 more |
2014-05-20 |
| 8722657 |
Salts and crystalline forms of an apoptosis-inducing agent |
Shuang Chen, Yuchuan Gong, Geoff G. Zhang |
2014-05-13 |
| 8513243 |
ABT-263 crystalline forms |
Geoff G. Zhang, Paul J. Brackemeyer, Thomas B. Borchardt |
2013-08-20 |
| 8362013 |
Salt of ABT-263 and solid-state forms thereof |
Thomas B. Borchardt, Paul J. Brackemeyer, Rodger F. Henry, Xiaochun Lou, Matthew M. Ravn +2 more |
2013-01-29 |
| 8362014 |
ABT-263 crystalline forms |
Geoff G. Zhang, Paul J. Brackemeyer, Thomas B. Borchardt |
2013-01-29 |